Effects of ankaferd blood stopper and celox on the tissue factor activities of warfarin-treated rats

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 1, 2014, Pages 16-21

  Aktop, Sertac ^a   Emekli Alturfan, Ebru ^a   Ozer, Cuneyt ^b   Gonul, Onur ^a   Garip, Hasan ^a   Yarat, Aysen ^a   Goker, Kamil ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

Ankaferd Blood Stopper; anticoagulants; Celox; chitosan; hemostasis; tissue factor

Indexed keywords

CHITOSAN; HEMOSTATIC AGENT; SODIUM CHLORIDE; THROMBOPLASTIN; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; HEALING; HEMOSTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT; SKIN CULTURE; SOFT TISSUE; SOFT TISSUE HEALING; TISSUE HOMOGENATE; WOUND HEALING;

ANKAFERD BLOOD STOPPER; ANTICOAGULANTS; CELOX; CHITOSAN; HEMOSTASIS; TISSUE FACTOR;

ANIMALS; BIOPOLYMERS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HEMOSTASIS; MALE; PLANT EXTRACTS; PROTHROMBIN TIME; RATS; RATS, WISTAR; SKIN; THROMBOPLASTIN; WARFARIN;

EID: 84890501267     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613490254     Document Type: Article

References (41)

1. Aframian DJ, Lalla RV, Peterson DE.. Management of dental patients taking common hemostasis altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 ; 103 (suppl 1). e1 - S45
2. Blinder D, Manor Y, Martinowitz U, Taicher S. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg. 2001 ; 30 (6). 518-521
3. Devani P, Lavery KM, Howell CJ. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?. Br J Oral Maxillofac Surg. 1998 ; 36 (2). 107-111
4. Salam S, Yusuf H, Milosevic A. Bleeding after dental extractions in patients taking warfarin. Br J Oral Maxillofac Surg. 2007 ; 45 (6). 463-466
5. Kurt M, Oztas E, Kuran S, Onal IK, Kekilli M, Haznedaroglu IC.. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med. 2009 ; 27 (5). e1-631
6. Fisgin NT, Tanriverdi Cayci Y, Coban AY, et al. Antimicrobial activity of plant extract Ankaferd Blood Stopper. Fitoterapia. 2009 ; 80 (1). 48-50
7. Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008 ; 36 (1). 163-170
8. Malette WG, Quigley H, Gaines RD, Johnson ND, Rainer WG. Chitosan: a new hemostatic. Ann Thorac Surg. 1983 ; 36 (1). 55-58
9. Klokkevold PR, Fukayama H, Sung EC, Bertolami CN. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. J Oral Maxillofac Surg. 1999 ; 57 (1). 49-52
10. Bachli E. History of tissue factor. Br J Haematol. 2000 ; 110 (2). 248-255
11. Emekli-Alturfan E, Kasikci E, Yarat A. Peanuts improve blood glutathione HDL-cholesterol level and change tissue actor activity in rats fed a high-cholesterol diet. Eur J Nutr. 2007 ; 46 (8). 476-482
12. Emekli-Alturfan E, Basar I, Alturfan AA, et al. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes. Pathophysiol Haemost Thromb. 2007 ; 36 (6). 290-297
13. Ingram GIC, Hills M. Reference method for the one stage prothrombin time test on human blood. Thromb Haemostas. 1976 ; 36 (1). 237-238
14. Tomizawa YJ. Clinical benefits and risk analysis of topical hemostats: a review. Artif Organs. 2005 ; 8 (3). 137-142
15. Sabel M, Stummer W. The use of local agents: surgical and Surgifoam. Eur Spine J. 2004 ; 13 (suppl 1). 97-101
16. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004 ; 13 (suppl 1). 89-96
17. Guralnick WC, Berg L. Gelfoam in oral surgery; a report of two hundred fifty cases. Oral Surg Oral Med Oral Pathol. 1948 ; 1 (7). 632-639
18. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001 ; 15 (1). 44-54
19. Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med. 2000 ; 10 (4). 139-143
20. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989 ; 86 (8). 2839-2842
21. Alturfan AA, Emekli-Alturfan E, Dariyerli N, et al. Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism. Endocrine. 2006 ; 30 (1). 63-67
22. Yarat A, Tunali T, Pisiriciler Akyuz S, Ipbuker A, Emekli N. Salivary thromboplastic activity in diabetics and healthy controls. Clin Oral Invest. 2004 ; 8 (1). 36-39
23. Mackman N. Role of tissue factor in hemostasis, thrombosis and vascular development. Arterioscler Thromb Vasc Biol. 2004 ; 24 (6). 1015-1022
24. Tuthill DD, Bayer V, Gallagher AM, Drohan WN, Macphee MJ. Assessment of topical hemostats in a renal hemorrhage model in heparinized rats. J Surg Res. 2001 ; 95 (2). 126-132
25. Haasch GC, Gerstein H, Austin PB.. Effects of two hemostatic agents on osseous healing. J Endod. 1989 ; 15 (7). 310-314
26. Elg M, Gustafsson D, Carlsson S. Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat. Thromb Res. 1999 ; 94 (3). 187-197
27. Alpaslan C, Alpaslan GH, Oygur T. Tissue reaction to three subcutaneously implanted local hemostatic agents. Br J Oral Maxillofac Surg. 1997 ; 35 (2). 129-132
28. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper® in children undergoing tonsillectomy. Int J Pediatr Otorhinolaryngol. 2009 ; 73 (12). 1742-1745
29. Göker H, Haznedaroglu IC, Erçetin S, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008 ; 36 (1). 163-170
30. Kosar A, Cipil HS, Kaya A, Uz B, Haznedaroǧlu IC. The efficacy of Ankaferd Blood Stopper® antithrombotic drug induced primary and secondary hemostatic abnormalities of a rat bleeding model. Blood Coagul Fibrinolysis. 2009 ; 20 (3). 185-190
31. Tokgöz H, Karakaya K, Hanci V, et al. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model. Urology. 2010 ; 75 (6). e9-1515
32. Cipil HS, Koşar A, Kaya A, Uz B, et al. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper® in rats pretreated with warfarin. Clin Appl Thromb Hemost. 2009 ; 15 (3). 270-276
33. Erçetin S, Haznedaroǧlu IC, Kurt M, et al. Safety and efficacy of Ankaferd Blood Stopper in dental surgery and bleeding. Int J Hematol Oncol. 2010 ; 20 (1). 1-5
34. Zacharski LR, Rosenstein R. Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy. Blood. 1979 ; 53 (3). 366-374
35. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006 ; 113 (5). 722-731
36. Kozen BG, Kircher SJ, Henao J, Godinez FS, Johnson AS. An alternative hemostatic dressing comparison of CELOX, HemCon, and QuikClot. Acad Emerg Med. 2008 ; 15 (1). 74-81
37. XIaohong W, YongnIan Y, Zhang R. A comparison of chitosan and collagen sponges as hemostatic dressing. J Bioact Compat Polym. 2006 ; 21 (1). 39
38. Huri E, Akgül T, Yücel O, AstarcI M, Üstün H, Germiyanoǧlu C. The second step in vitro trial of Ankaferd Blood Stopper: comparison with the other hemostatic agents. Turk J Med Sci. 2011 ; 41 (1). 7-15
39. Nicholson AC, Nachman RL, Altieri DC, et al. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem. 1996 ; 271 (45). 28407-28413
40. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000 ; 407 (6801). 258-264
41. Ollivier V, Chabbat J, Herbert JM, Hakim J, de Prost D. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Arterioscler Thromb Vasc Biol. 2000 ; 20 (5). 1374-1381